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Investigation of International Traveler with Multidrug-Resistant 
Tuberculosis (MDR TB)
The Centers for Disease Control and Prevention (CDC) is working with international, state, and local health 
officials and other partners on an investigation involving an international traveler to the U.S. who had recently 
been diagnosed with multidrug-resistant tuberculosis (MDR TB).
CDC was informed in mid-December 2007 by a local health authority that a patient who had been diagnosed in 
India with MDR TB traveled from New Delhi, India to Chicago, Illinois on December 13, 2007 on American Airlines 
Flight # 293 and then on a shorter flight within the United States. Shortly after final arrival, the patient sought 
treatment for hemoptysis, fever, and chest pain at a hospital. These and other findings indicated a potential for 
transmission of drug-resistant TB infection to others. The patient has been hospitalized in airborne isolation and 
is receiving treatment for TB.
Shortly after being notified about the patient and her travels, officials of CDC's Division of Global Migration and 
Quarantine contacted American Airlines and U.S. Customs and Border Protection to obtain the information 
needed to contact passengers who may have been exposed to the traveler with tuberculosis. CDC is 
collaborating with U.S. state and local health departments, the Indian Ministry of Family Welfare, American 
Airlines, and the Department of Homeland Security's Customs and Border Protection to ensure notification and 
follow-up of passengers and crew who may have been exposed to MDR TB.
In accordance with the World Health Organization (WHO) TB and Airline Travel Guidelines, CDC is ensuring 
appropriate follow-up and care for persons who may have been exposed to TB on an aircraft. This includes 
recommending the evaluation and testing of passengers and crew with closest contact to the patient on board 
American Airlines Flight #293 departing from New Delhi, India on December 13, 2007 and arriving in Chicago, 
Illinois on December 13, 2007. This includes 44 passengers. These were the passengers seated in the same row 
as the index patient (row 35), and those seated in the two rows ahead (rows 33 and 34) and the two rows behind 
(rows 36 and 37), as well as the crew members working in the same cabin. These persons should receive an 
initial evaluation and testing for TB infection, with follow-up 8 to 10 weeks after the December 13 flight for re­
evaluation.
CDC recommends testing of these passengers and crew on only the international flight from New Delhi to 
Chicago because this flight was longer than the 8 hour duration criteria specified by WHO for passenger testing 
for exposure to tuberculosis. WHO and CDC do not recommend notification or medical evaluation of passengers 
on briefer flights because the risk of transmission is minimal. WHO guidelines can be found at 
http://whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006.363_eng.pdf
CDC issued an Epi-X notification on December 28, 2007 to health officials in 17 states based on locating 
information provided by 42 of the 44 potentially exposed passengers. (Locating information was not available on 
two passengers). These states include California, Colorado, Florida, Georgia, Illinois, Indiana, Kansas, Michigan, 
Minnesota, Missouri, New Jersey, North Carolina, Ohio, Tennessee, Texas, Vermont, and Virginia. These states 
should inform CDC's Division of Global Migration and Quarantine's duty officer if they are unable to contact any of 
the passengers with destinations in their states. The duty officer can be reached by calling CDC's Director's 
Emergency Operation Center (DEOC) at (770) 488-7100.
Drug-susceptible (regular) TB and MDR TB are thought to be spread the same way. The risk of acquiring any 
type of TB appears to depend on several factors, such as extent of disease in the source patient, duration of 
exposure, and ventilation. TB bacilli become aerosolized when a person with TB disease of the lungs or throat 
coughs, sneezes, speaks, or sings. These bacilli can float in the air for several hours, depending on the 
environment. Persons who breathe air containing these TB bacilli can become infected. Transmission has been 
documented in association with patients who have TB lung disease, and bacteria seen or cultured in sputum. 
Persons who become infected usually have been exposed for several hours (or days) in poorly ventilated or 
crowded environments. An important way to prevent the spread and transmission is by limiting an infectious 
person's contact with other people. Thus, people who have suspected or confirmed TB or MDR TB that is 
potentially infectious should be placed on treatment and kept isolated until they are no longer infectious.
State and local health departments who want additional information may contact CDC's Division of Global 
Migration and Quarantine's duty officer through the CDC Director's Emergency Operation Center (DEOC) at (770) 
488-7100.
Persons who believe they may have been exposed to TB or MDR TB, or their clinicians, can call 1 -800 CDC 
INFO for further information.




TB Testing: http://www.cdc.gov/tb/pubs/tbfactsheets/skintesting.htm and 
http://www.cdc.gov/tb/pubs/tbfactsheets/QFT.htm
Infection control: http://www.cdc.gov/tb/pubs/tbfactsheets/ichcs.htm and 
http://www.cdc.gov/tb/pubs/tbfactsheets/rphcs.htm
Tuberculosis and Air Travel: http://whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006.363_eng.pdf
The Centers fo r Disease Control and Prevention (CDC) protects people's health and safety by preventing and 
controlling diseases and in juries; enhances health decisions by providing credible inform ation on critical health 
issues; and promotes healthy living through strong partnerships w ith local, national and international
organizations.
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